Guillauma dupuytren'den 178 yıl sonra dupuytren hastalığı: 18 olgu eşliğinde literatürün gözden geçirilmesi

1989 yılı ile 2010 yılı arasında takip ve tedavi edilen 18 olgu sunuldu. Hastaların 15’i erkek, 3’ü kadın olmak üzere tüm olguların 6'sında hastalık iki yanlı idi. En sık tutulan palmar fasiya bölgesi 4. parmak rayına ait bölge oldu. Bunu 5. parmak ve 3. parmak sırası ile izledi. Hiç 2. parmak bölgesinde nodülü olup da gelen hastamız olmadı. Bütün olgularda genel anestezi (n:16) ve her zaman turnike altında çalışıldı. Sadece 2 olguda rejiyonal intravenöz anestezi tekniği kullanıldı. İki yanlı olgularda eş zamanlı olarak iki tarafı da ameliyat edilen hastalar da oldu. Bütün ameliyatlardan sonra ameliyat alanı içerisine Penrose diren yerleştirildi. Ameliyat sırasında çıkarılan tüm dokular histopatolojik değerlendirme için patoloji laboratuarına gönderildi. Eşlik eden hastalıklar ve bulgu-lar olarak hastaların 3’ünde diyabetes mellitus dikkati-mizi çekerken, diğer tür fibromatöz bulguları olan sadece 1 hastamız oldu ki onun da pilantar fibromatozisi vardı. Bize genellikle erken dönemde hastalar başvurdu. Tüm olgular arasında 30 dereceden daha fazla fleksiyon kontraktürü ile gelenlerin sayısı 3 oldu. Hastalarımızdan 3 tanesi daha önce de aynı sebeple ameliyat edilmişlerdi. Nüks olgulardan birinde ameliyat sonrası cilt fleplerinde kısmi nekroz gelişti ve defekt alan küçük olduğundan ikincil iyileşmeye bırakıldı. Ameliyat sonrası sonuçlar tatminkar oldu. Bazı olgularımızda (n:2) patolojik doku etrafında Pasini cisimciklerinin hiperplazik ve hipertrofik olduklarına da şahit olundu.

Dupuytren disease 178 years after Guillauma Dupuytren: A look out to the literature under the guidance of 18 cases

We presented 18 cases with Dupuytren’s disease treated surgically from 1989 to 2010. 15 of cases were male and 3 of them were female. The disease was bilateral in 6 cases. The most common involved palmar fascia region was 4th finger’s ray. It was followed by 5th and 3rd respectively. There were no patient that has had 2nd finger involvement. We worked under general anesthesia (n:16) and pneumatic tourniquet in all cases. Only in two cases we used regional intravenous anestheisa. Among the bilaterally involved patients there were some cases in which we operated on both sides at the same session. A Penrose drain was inserted after operation in all cases. We sent all speciemens to the pathology laboratory after the operation for histopathologic examination. Diabetes mellitus was noted as associated problem in 3 cases and there was only one cases that included an associated fibromatosis condition. Generally patients were in early contracture stages. Only three cases were found with contractures much more than 30 degrees. Three cases were associated with reccurrent disease and they had already been operated on before. Among this recurrent contractures, marginal skin necrosis existed and we şeft it secondary healing. We satisfied with the results obtained. We also observed somewhat hyperplastic and hypertrophic Pascini corpuscle in two cases.

___

  • 1. Lubahn JD. Dupuytren’s Disease, In: Chapman MW (editor) Chapman’s Orthopedic Surgery, Lipincot-Wlliams and Wilkins, Philadelphia, 2001;pp: 1735-46.
  • 2. Thruston AJ. Dupuytren’s Disease. J Bone and Joint Surg 2003;85: 469-77.
  • 3. Saar JD, Grothaus PC. Dupuytren’s Disease: an overview. Plast Reconstr Surg 2000;106: 125-34.
  • 4. Georgiade GS, Georgiade NG, Riefkahl R, Barwick WJ (Eds). Textbook of Plastic, Maxillofacial and Reconstructive Surgery, 2nd Ed, Williams Wilkins, Baltimore 1992.
  • 5. Wilbrand S, Ekbonm A, Gerdin B. A cohort study linked increased mortality in patients treated surgically for Dupuytren’s contracture. J Clin Epidemiol 2005;58: 68-74.
  • 6. Trojian TH, Chu SM. Dupuytren’s disease: diagnosis and treatment. Am Fam Physician 2007;76: 86-9.
  • 7. Lellouche H. Dupuytren’s contracture: surgery is no longer necessary. Presse Med 2008;37: 1779-81.
  • 8. Denkler K. Dupuytren’s fasciectomies in 60 consecutive digits using lidocaine with epinephrine and no tourniquet. Plast Reconstr Surg 2005;115: 802-10.
  • 9. Yenidunya MO, Yenidunya S, Seven E. Pacinian hypertrophy in a type 2A hand burn contracture and Pacinian hypertrophy and hyperplasia in a Dupuytren's contracture. Burns 2009;35: 446-50.
  • 10. Marcuzzi A, Ruggiero L, Chirila L, Gilardi R, Landi A. Dupuytren’s disease of the radial side of the hand. Eur J Plast Surg 2009;32: 275-81.
  • 11. Degreef I, Vererfve PB, De Smet L. Effect of severity of Dupuytren contracture on disability. Scand J Plast Reconstr Surg Hand Surg 2009;43: 41-2.
  • 12. Augoff K, Kula J, Gosk J, Rutowski R. Epidermal growth factor in Dupuytren’s disease. Plast Reconstr Surg 2005;115: 128-33.
  • 13. Saboeiro AP, Pokorny JJ, Shehadi SI, Virgo KS, Johnson FE. Racial distrubition of Dupuytren’s disease in department of veterans affairs patients. Plast Reconstr Surg 2000;106: 71-5.
  • 14. Yenidünya MO. Plastik ve Rekonstrüktif Cerrahiye Giriş, Bilimsel Tp Yaynevi, Ankara 1999.
  • 15. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s Disease. 8 year follow-up. J Hand Surg Am 2010;35: 534-9.
  • 16. Swartz WM., Lalonde DH. Dupuytren’s Disease. Plast Reconst Surg 2008;121: 1-10.
  • 17. Abe Y, Rokkaku T, Ebata T, Tokunaga S, Yamada T. Dupuytren’s disease following acute injury in Japanese patients: Dupuytren’s disease or not? J Hand Surg Eur 2007;32: 569-72.
  • 18. Loos B, Puschkin V, Horch RE. 50 years experince with Dupuytren’s contracture in the Erlange University Hospital a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculosceletal Disord 2007;8: 60.
  • 19. Habash A, Rinker B. Dupuytren’s disease involving the wrist. J Hand Surg Am 2007;32: 352-4.
  • 20. Pan D, Watson HK, Swigart C, Thomson JG, Honig SC, Narayan D. Microarray gene analysis and expression profiles of Dupuytren’s Contracture. Annals of Plastic Surg 2003;50: 618-22.
  • 21. Degreef I, Smet LD, Sciot R, Cassiman JJ, Tejpar S. Immunohistochemical evidence for Zic-1 coexpression with beta catenin in the myofibroblast of Dupuytren disease. Scand J Plast Reconstr Surg 2009;43: 36-40.
  • 22. Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metallloproteinases in sera and tissue of patients with Dupuytren’s Disease. Plast Reconstr Surg 2003;12: 1279-86.
  • 23. Bayat A, Walter J, Lambe H, Watson JS, Stanley JK, Marino M, et al. Identification of a novel mitochondrial mutation in Dupuytren’s disease using multiplex DHPLC. Plast Reconstr Surg 2005;115: 134-41.